neuroprotective products market moving towards n.
Skip this Video
Loading SlideShow in 5 Seconds..
Neuroprotective Products Market : Expected to Consume the Largest Market Share by 2023 PowerPoint Presentation
Download Presentation
Neuroprotective Products Market : Expected to Consume the Largest Market Share by 2023

Neuroprotective Products Market : Expected to Consume the Largest Market Share by 2023

1 Vues Download Presentation
Télécharger la présentation

Neuroprotective Products Market : Expected to Consume the Largest Market Share by 2023

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Neuroprotective Products Market : Moving Towards Brighter Future Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunity Analysis and Industry Forecast, 2017-2023

  2. Neuroprotective Products Market Neuroprotective products are medications that protect the brain neurons from degeneration and injury. These products are used in the treatment of several central nervous system complications such as Parkinson's disease, Alzheimer's disease, and traumatic brain injuries among others. Neurodegenerative diseases and their prevalence increases significantly with age. Hence, the demand for neuroprotectives would increase in the future, as average life spans are increasing, which opens up a huge market for novel drugs for the treatment of these diseases. The drivers for this market are the increasing incidence and prevalence of neurodegenerative diseases, especially in aging populations and a need for the treatment of brain injuries caused chiefly by road accidents.

  3. Neuroprotective Products Market by Class of Drugs The neuroprotective drugs are Cholinesterase inhibitors, NMDA receptor antagonists, Ion channel modulators, Anti-inflammatory and anti-apoptotic agents, Mitochondrial dysfunction regulators Neurotropic factors, Anti excitotoxic agents , Ion channel modulators, Metal Ion Chelators Free radical trappers, and others. The Cholinesterase inhibitors and NMDA receptor antagonists are used to treat Alzheimers. As the disease burden is high for this ailment, these drugs would command a major market share. However, the opportunity for emerging drugs is high, as CNS disorders involve an interplay of highly complex and multi- factorial processes & pathways. Therefore, investment in research and development would have high pay offs.

  4. Competitive Analysis of Neuroprotective Products Market Genervon Biopharmaceuticals, NeuroVive Pharmaceutical,Ceregene, BHRPharma LLC, Neuren Pharmaceuticals, Allon therapeutics, Inc., Bionure Inc. are some of the key players in this market. In 2013, Bionure and The Myelin Repair Foundation (MRF) entered into a collaborative partnership agreement with the aim of advancing development of therapeutics for multiple sclerosis. This partnership would enable the commercialization of many promising compounds for the treatment of multiple sclerosis.

  5. Key Benefits of Neuroprotective Products Market • Competitive analysis of companies and policies adopted by competitors would help in making strategic decisions In-depth analysis of current market scenario would help in understanding opportunities in this market Segmentation based on applications would help in understanding future growth prospects and areas where investments can be made. Analysis of drivers and restrains focuses on the opportunities and risks of this market, which would enable decision-making Estimations of growth in this market based on upcoming drugs would give an overall idea of areas of growth to stakeholders. • • • •

  6. Neuroprotective Products Market North America Europe Asia-Pacific LAMEA

  7. Neuroprotective Products Market Thank You! For More Details Visit us at and-sample/262 Follow Us On